He Mu Biotechnology Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Series A1

  • Investors
  • 5

He Mu Biotechnology General Information

Description

Developer of animal mRNA vaccines in China designed to protect the development of the animal husbandry industry. The company's vaccines provide a comprehensive solution for pathogen detection and prevention and include more than ten animal mRNA vaccines for pigs, cattle and pets, enabling the animal husbandry industry in China to protect its livestock against viral diseases.

Contact Information

Website
www.hemubio.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Room 1503, 15th Floor, Building D, Tsinghua Tongfang Science and Technology Building
  • Number 1 Wangzhuang Road, Haidian District
  • Beijing, 100000
  • China
+86 186
Primary Industry
Other Commercial Products
Vertical(s)
AgTech, Life Sciences
Corporate Office
  • Room 1503, 15th Floor, Building D, Tsinghua Tongfang Science and Technology Building
  • Number 1 Wangzhuang Road, Haidian District
  • Beijing, 100000
  • China
+86 186

He Mu Biotechnology Timeline

2023202420252026
Date FoundedFinancing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

He Mu Biotechnology Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Early Stage VC (Series A1) 15-Jan-2026 Completed Generating Revenue
6. Early Stage VC (Series A) 03-Nov-2025 Completed Generating Revenue
5. Early Stage VC 23-Apr-2024 Completed Generating Revenue
4. Secondary Transaction - Private 08-Jan-2024 Completed Generating Revenue
3. Early Stage VC 12-Dec-2023 Completed Generating Revenue
2. Seed Round 05-Jan-2023 $2.23M $2.23M Completed Startup
1. Seed Round 21-Oct-2022 Completed Startup
To view He Mu Biotechnology’s complete valuation and funding history, request access »

He Mu Biotechnology Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Hebei Airport Economic Zone Private Equity Fund Management PE/Buyout Minority
Asia Green Fund Impact Investing Minority
Tsinghua Capital Venture Capital Minority
China-U.S. Green Fund PE/Buyout Minority
Tianjin Yiyi Hygiene Products Corporation Minority
To view He Mu Biotechnology’s complete investors history, request access »

Ready to get started?

Request a free trial

He Mu Biotechnology FAQs

  • When was He Mu Biotechnology founded?

    He Mu Biotechnology was founded in 2022.

  • Where is He Mu Biotechnology headquartered?

    He Mu Biotechnology is headquartered in Beijing, China.

  • What industry is He Mu Biotechnology in?

    He Mu Biotechnology’s primary industry is Other Commercial Products.

  • Is He Mu Biotechnology a private or public company?

    He Mu Biotechnology is a Private company.

  • What is He Mu Biotechnology’s current revenue?

    The current revenue for He Mu Biotechnology is .

  • How much funding has He Mu Biotechnology raised over time?

    He Mu Biotechnology has raised $2.23M.

  • Who are He Mu Biotechnology’s investors?

    Hebei Airport Economic Zone Private Equity Fund Management, Asia Green Fund, Tsinghua Capital, China-U.S. Green Fund, and Tianjin Yiyi Hygiene Products have invested in He Mu Biotechnology.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process